Welcome to LookChem.com Sign In|Join Free
  • or
2-(benzyloxy)-5-methoxy-N-(pyridin-3-yl)benzamide is an organic compound with the molecular formula C23H21N2O3. It is a benzamide derivative characterized by a benzene ring substituted with a benzyloxy group and a methoxy group, along with a pyridine ring attached to the amide nitrogen. 2-(benzyloxy)-5-methoxy-N-(pyridin-3-yl)benzamide may exhibit diverse biological activities due to its unique structure, including potential antitumor, anti-inflammatory, and antipsychotic properties.

1285513-33-8

Post Buying Request

1285513-33-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1285513-33-8 Usage

Uses

Used in Pharmaceutical Industry:
2-(benzyloxy)-5-methoxy-N-(pyridin-3-yl)benzamide is used as a potential pharmaceutical candidate for its diverse biological activities. The presence of the benzyloxy and methoxy groups, along with the pyridine ring, suggests that 2-(benzyloxy)-5-methoxy-N-(pyridin-3-yl)benzamide may have antitumor, anti-inflammatory, and antipsychotic properties. Its potential interactions with biological systems containing nicotinic receptors also warrant further investigation.
Further research is needed to fully understand the potential uses and effects of 2-(benzyloxy)-5-methoxy-N-(pyridin-3-yl)benzamide, as its specific applications and therapeutic outcomes are yet to be determined.

Check Digit Verification of cas no

The CAS Registry Mumber 1285513-33-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,5,5,1 and 3 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1285513-33:
(9*1)+(8*2)+(7*8)+(6*5)+(5*5)+(4*1)+(3*3)+(2*3)+(1*3)=158
158 % 10 = 8
So 1285513-33-8 is a valid CAS Registry Number.

1285513-33-8Downstream Products

1285513-33-8Relevant academic research and scientific papers

Discovery of 5-substituent-N-arylbenzamide derivatives as potent, selective and orally bioavailable LRRK2 inhibitors

Ding, Xiao,Dai, Xuedong,Long, Kai,Peng, Cheng,Andreotti, Daniele,Bamborough, Paul,Eatherton, Andrew J.,Edge, Colin,Jandu, Karamjit S.,Nichols, Paula L.,Philps, Oliver J.,Stasi, Luigi Piero,Wan, Zehong,Xiang, Jia-Ning,Dong, Kelly,Dossang, Pamela,Ho, Ming-Hsun,Li, Yi,Mensah, Lucy,Guan, Xiaoming,Reith, Alastair D.,Ren, Feng

, p. 4034 - 4038 (2017/08/23)

Leucine-rich repeat kinase 2 (LRRK2) has been suggested as a potential therapeutic target for Parkinson's disease. Herein we report the discovery of 5-substituent-N-arylbenzamide derivatives as novel LRRK2 inhibitors. Extensive SAR study led to the discovery of compounds 8e, which demonstrated potent LRRK2 inhibition activity, high selectivity across the kinome, good brain exposure, and high oral bioavailability.

NOVEL COMPOUNDS

-

, (2011/04/25)

The present invention discloses novel compounds inhibiting LRRK2 kinase activity, the preparation processes thereof, the compositions containing them, as well as the use in treating diseases characterized by LRRK2 kinase activity, particularly Parkinson's disease and Alzheimer's disease.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1285513-33-8